Angus Jones is an Associate Professor at the University of Exeter, and an Honorary Consultant Physician at the Royal Devon and Exeter Hospital. He trained in medicine in London and completed his PhD with Professor Andrew Hattersley in Exeter, studying the clincial utility of C-peptide testing in diabetes management. His research interests are in precision approaches to the management of diabetes, with a focus on practical approaches that can impact clincial practice now or in the near future. This includes approaches to improving clincial classification of diabetes, both though optimising use of classification biomarkers such as C-peptide and islet autoantibodies, and through development of prediction models to combine clincial features and biomarkers to guide diabetes classification and treatment. Additional interests include developing stratified approaches to treatment of type 2 diabetes, and, as part of his work as research lead and Deputy Director of The University of Exeter NIHR Global Health Group, approaches to effective diabetes diagnosis, monitoring and classification in low resource settings. He has previously been awarded National Institute of Health Research (NIHR) Doctoral and Clinician Scientist fellowships, and a Rising Star award from the European Association for the Study of Diabetes.